Shiqi Ma
Radiation Oncology Key Laboratory Of Sichuan Province
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dysregulation of peripheral and intratumoral KLRG1+ CD8+T cells is associated with immune evasion in patients with non-small-cell lung cancer.
Journal: Translational oncology
Published: January 25, 2024
Corrigendum to "ErbB3 ligand, Heregulin1, is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation" [Neoplasia 21 (2019) 343-352].
Journal: Neoplasia (New York, N.Y.)
Published: March 31, 2021
Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer.
Journal: Oncogene
Published: September 25, 2020
The Dynamic Expression of Potential Mediators of Severe Acute Respiratory Syndrome Coronavirus 2 Cellular Entry in Fetal, Neonatal, and Adult Rhesus Monkeys.
Journal: Frontiers in genetics
Published: September 17, 2020
ErbB3 Ligand Heregulin1 Is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation.
ErbB3 Ligand Heregulin1 Is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation.
Journal: Neoplasia (New York, N.Y.)
Published: October 03, 2018
An EV-Associated Gene Signature Correlates with Hypoxic Microenvironment and Predicts Recurrence in Lung Adenocarcinoma.
Journal: Molecular therapy. Nucleic acids
Published: September 28, 2018
Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
Journal: Journal of translational medicine
Published: October 15, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026